Live Breaking News & Updates on Cenova Ventures

Stay updated with breaking news from Cenova ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Chinese biopharma firm IMPACT closes $55m Series D+ round to advance cancer drugs

The Series D+ round was led by GTJA Investment Group and Beijing-based state capital investor Kingray Capital. ....

Leiwen Chen , Junshi Biosciences , National Medical Products Administration , Yangzhou Guojin Group , Investment Group , Drug Administration , Yangzhou City , Lilly Asia Ventures , New Drug Application , Kingray Capital , Eikon Therapeutics , Hong Kong Listed , Wuxi Apptec , Cenova Ventures , Decheng Capital ,